Home › Funds › XPONANCE LLC › ABBV

XPONANCE LLC position in ABBV

ABBVIE INC · Health Care

XPONANCE LLC reported holding 363,832 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$95.2M, representing 0.55% of its reported portfolio and ranking #26 among its reported holdings. XPONANCE LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)363.83K sh
Reported value held$95.17M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How XPONANCE LLC's ABBV position evolved

XPONANCE LLC first disclosed a stake in ABBV in Q3 2023 at 405,599 shares (US$60.5M). The position peaked in Q1 2026 at 511,945 shares, worth US$111.3M. Across 13 filings, XPONANCE LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 363,832 shares valued at US$95.2M — an increase of 12,920 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2025 (shares rose 26% over the following quarter), a 31% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 405.60K $60.46M New
Q4 2023 412.60K $63.94M Add
Q1 2024 419.40K $76.37M Add
Q2 2024 332.59K $57.05M Reduce
Q3 2024 339.50K $67.05M Add
Q4 2024 338.87K $60.22M Hold
Q1 2025 343.47K $71.96M Add
Q2 2025 451.27K $83.77M Add
Q3 2025 463.65K $107.35M Add
Q4 2025 479.55K $109.57M Add
Q1 2026 511.94K $111.34M Add
Q2 2026 350.91K $88.30M Reduce
Q3 2026 363.83K $95.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has XPONANCE LLC held ABBV?

XPONANCE LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is XPONANCE LLC's current position in ABBV?

As of Q3 2026, XPONANCE LLC holds 363.83K shares of ABBV (ABBVIE INC), valued at $95.17M, representing 0.55% of its reported portfolio and ranking #26.

Has XPONANCE LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), XPONANCE LLC increased its position in ABBV. The position peaked in Q1 2026 at 511.94K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.